The global mechanical ventilator market size was valued at USD 7.96 billion in 2022. It is estimated to reach USD 10.08 billion by 2031, rising at a CAGR of 5.3% during the forecast period (2023–2031). Factors such as export ban of critical care equipment and technological advancements, significantly drives the mechanical ventilator market demand by 2031.
Mechanical ventilators remove carbon dioxide out of the body and provide oxygen-rich air into the lungs. By inserting a breathing tube into the patient's airway and providing a regulated flow of air or a combination of air and oxygen, they help patients breathe. Depending on the patient's requirements, the ventilator can be configured to give different air pressures or volumes. Various breathing modes, including volume control, pressure control, and positive end-expiratory pressure (PEEP), are available with mechanical ventilators. These modes let medical personnel adjust the ventilator settings to suit the requirements of each patient.
In a number of medical circumstances, such as respiratory failure, acute lung damage, pneumonia, chronic obstructive pulmonary disease (COPD), and general anesthesia-requiring surgery, mechanical ventilators are crucial. For patients with impaired respiratory function, mechanical ventilation aids enhance oxygenation and carbon dioxide removal while providing life-sustaining assistance.
Governments of various countries are implementing temporary trade measures that aim at restricting exports of vital medical supplies, such as masks and ventilators. According to a report by the Global Trade Alert in March 2020, about 54 governments around the globe, most of them in the Asia-Pacific and Europe, restricted the export of medical supplies. Some countries that restrict exports are the UK, France, Italy, Germany, China, Russia, India, Saudi Arabia, Pakistan, Egypt, Indonesia, Vietnam, and Malaysia.
The largest producers of mechanical ventilators are in the U.S., China, and Germany. These countries accounted for USD 500 million in sales of overall ventilators worldwide as of 2019. Around 50% of ventilator manufacturers are located across Europe and have restricted the export to other countries. This may encourage local manufacturers to enhance the production of mechanical ventilators, which can help the market growth. For instance, in India, AgVa Healthcare, a manufacturer of portable mechanical ventilators, is helping the government by increasing the supply and production of ventilators. The Indian government also asked the company to deliver 5,000 units by April 15, 2020.
In light of the unprecedented demand for ventilators during the COVID-19 pandemic, numerous manufacturers and companies took proactive measures to meet the urgent needs of healthcare facilities and patients. One significant step they took was establishing dedicated assembly lines for ventilator production. These assembly lines have been set up with the primary objective of increasing the production capacity of ventilators to ensure an adequate supply for patients requiring respiratory support.
Manufacturers have significantly invested in additional equipment, resources, and workforce to increase production capacity. These investments aim to scale the manufacturing process to meet the surging demand rapidly. By dedicating assembly lines solely to ventilator production, manufacturers can optimize the utilization of resources and streamline the manufacturing process to achieve maximum efficiency.
Establishing assembly lines for ventilator production has been a crucial step in addressing the surge in demand caused by the COVID-19 pandemic. However, manufacturers in the market continue to face several restraints and bottlenecks that can impede the scaling up of production. One significant challenge is the disruption of global supply chains. The pandemic disrupted the availability of critical components, raw materials, and specialized parts needed for ventilator manufacturing. Travel restrictions, lockdown measures, and increased demand for these supplies have resulted in delays and shortages, affecting the production capacity of manufacturers.
The lack of skilled personnel is a further obstacle. As the demand for ventilators skyrocketed, manufacturers faced challenges acquiring enough skilled workers to operate the assembly lines efficiently. The complexity of ventilator production requires specialized knowledge and expertise, and the sudden surge in demand overwhelms the existing workforce. The shortage of skilled labor can further slowdown production and hinder efforts to meet the increasing demand for mechanical ventilators.
Technological advancements in mechanical ventilators offer significant opportunities for manufacturers to enhance the performance and functionality of these devices. Improved monitoring capabilities enable real-time monitoring of patients’ respiratory parameters, such as tidal volume, respiratory rate, and oxygen saturation, allowing healthcare providers to monitor and adjust ventilation settings as needed closely. Integration with electronic medical records facilitates seamless data exchange and documentation, streamlining patient care and improving workflow efficiency.
Additionally, wireless connectivity enables remote monitoring and control of ventilators, allowing healthcare professionals to monitor multiple patients simultaneously and make adjustments without being physically present at the bedside. This technology also enables data sharing and analysis, which can contribute to research and developing evidence-based ventilator management protocols.
| Study Period | 2019-2031 | CAGR | 5.3% |
| Historical Period | 2019-2021 | Forecast Period | 2023-2031 |
| Base Year | 2022 | Base Year Market Size | USD 7.96 Billion |
| Forecast Year | 2031 | Forecast Year Market Size | USD 10.08 Billion |
| Largest Market | North America | Fastest Growing Market | Europe |
Based on region, the global mechanical ventilator market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the most significant global market shareholder and is estimated to grow at a CAGR of 2.8% over the anticipated period. In 2020, North America held the greatest market share, at over 60.0%, and is anticipated to continue to dominate over the forecast period. It is anticipated that mechanical ventilators will increase in this area due to the rising number of hospitalizations brought on by the coronavirus pandemic and the largest number of patients requiring ventilation in the United States. Moreover, North America is at the forefront of technological advancements and innovation in the healthcare sector. The region's strong focus on research and development, coupled with substantial investments in healthcare technologies, promotes the adoption of advanced mechanical ventilators. These ventilators have advanced monitoring capabilities, integrated electronic medical records, and wireless connectivity, enhancing patient care and improving healthcare provider efficiency.
Europe is estimated to exhibit a CAGR of 5.2% over the forecast period. Several factors contribute to this growth in the region, such as the availability of reimbursement coverages plays a crucial role in propelling the adoption of mechanical ventilators in Europe. Patients and healthcare facilities can afford these therapies and devices with favorable reimbursement policies, increasing market demand. The affordability of therapies and devices is another significant factor contributing to European market growth. In addition, the region offers a range of cost-effective mechanical ventilators, making them more accessible to a broader patient population. This affordability factor positively impacts the adoption of mechanical ventilation treatments. Europe is also home to several major market players in the mechanical ventilators industry. Companies like Drägerwerk AG and Air Liquide Healthcare have a strong presence and contribute to the market's growth through product approvals, acquisitions, and investments in research and development. The market growth is a direct result of their knowledge and constant innovation.
The Asia-Pacific market is expected to witness a surging demand during the forecast period owing to the increased spending power of consumers. The increasing elderly population and rising prevalence of chronic disorders, such as COPD, are expected to boost regional growth. Rising awareness, increasing disposable income, technological advancements, and various collaborations and strategic agreements are also anticipated to boost the mechanical ventilators market. For instance, Air Liquide 2017 acquired OxyMaster and Sogo Sangyo Kabushiki Kaisha to expand the household healthcare product portfolio across Asia Pacific. However, the high cost of products may hamper the market.
Latin America comprises several developing countries, and its mechanical ventilators market is expected to grow significantly. One of the primary drivers of market growth is the increase in the geriatric population. Also, elderly people are more susceptible to developing respiratory diseases due to age-related decline in lung function and weakened immune systems. This growing demographic presents a substantial market opportunity for mechanical ventilators, as these devices are crucial in providing respiratory support to patients with acute and chronic respiratory conditions.
In the Middle East and Africa, patients are increasingly aware of respiratory diseases and the available treatment options, including mechanical ventilation. This increased awareness leads to early diagnosis and intervention, further propelling the demand for mechanical ventilators in the region. Technological advancements also play a substantial role in driving market growth in the Middle East and Africa. As new technologies and innovations emerge, mechanical ventilators become more efficient, user-friendly, and equipped with advanced features. This leads to improved patient outcomes and enhances the overall quality of respiratory care. Integrating advanced technologies like wireless connectivity, data analytics, and remote monitoring enables better patient management and facilitates healthcare professionals' decision-making.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global mechanical ventilator market share is bifurcated into whitening products.
Based on products, the global market is bifurcated into critical care, neonatal, transport and portable, and others.
The critical care segment dominates the global market and is estimated to grow at a CAGR of 4.1% over the forecast period. The strong market dominance of the critical care segment can be attributed to several factors. Firstly, critical care ventilators are essential for providing life-saving respiratory support to patients with severe respiratory failure or acute respiratory distress syndrome (ARDS). These conditions often require advanced ventilation modes, precise control of parameters, and sophisticated monitoring capabilities provided by critical care ventilators. Additionally, the demand for critical care ventilators has been further amplified by the COVID-19 pandemic. The virus caused a surge in respiratory complications, leading to a higher need for mechanical ventilators in intensive care units (ICUs) to support patients with severe COVID-19-related respiratory distress.
Furthermore, technological advancements in critical care ventilators have contributed to their market dominance. Manufacturers continually develop innovative features and functionalities, such as improved algorithms for synchronized ventilation, enhanced user interfaces, and connectivity options for seamless integration with hospital systems. These advancements enhance patient care, improve ease of use for healthcare professionals, and drive the adoption of critical care ventilators.
Neonatal is anticipated to exhibit a CAGR of 4.6% over the forecast period. The respiratory rate of neonates is different from adults. Hence, specifically designed ventilators are needed for neonatal needs. The monitoring systems utilized in these are expected to be extremely precise to prevent any delay or ignorance on the part of the clinical staff. The category is anticipated to develop profitably over the following seven years due to the increase in the neonatal population and advancements in newborn care. The neonatal population growth would be driven due to increase in fertility rates of women and increased childbearing age with various races. Moreover, increasing technological advancements and introducing efficient neonate ventilators will propel market growth. For instance, in March 2015, the Hamilton-MR1 ventilator received a CE mark to extend its ventilator for neonatal option. The ventilator allows patients to travel from the ICU to the MRI suite without a change in the ventilator.
